These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 15240671

  • 1. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning.
    Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, Kirby SL, Luster AD, McKinnon K, Blazar BR, Serody JS.
    J Immunol; 2004 Jul 15; 173(2):845-54. PubMed ID: 15240671
    [Abstract] [Full Text] [Related]

  • 2. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.
    Welniak LA, Wang Z, Sun K, Kuziel W, Anver MR, Blazar BR, Murphy WJ.
    Exp Hematol; 2004 Mar 15; 32(3):318-24. PubMed ID: 15003318
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alloreactive T Cells Display a Distinct Chemokine Profile in Response to Conditioning in Xenogeneic GVHD Models.
    Kawasaki Y, Sato K, Nakano H, Hayakawa H, Izawa J, Takayama N, Mashima K, Oh I, Minakata D, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Fujiwara SI, Ohmine K, Muroi K, Ito R, Hayakawa M, Ohmori T, Kanda Y.
    Transplantation; 2019 Sep 15; 103(9):1834-1843. PubMed ID: 31461746
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease.
    Serody JS, Burkett SE, Panoskaltsis-Mortari A, Ng-Cashin J, McMahon E, Matsushima GK, Lira SA, Cook DN, Blazar BR.
    Blood; 2000 Nov 01; 96(9):2973-80. PubMed ID: 11049973
    [Abstract] [Full Text] [Related]

  • 7. Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.
    Mapara MY, Leng C, Kim YM, Bronson R, Lokshin A, Luster A, Sykes M.
    Biol Blood Marrow Transplant; 2006 Jun 01; 12(6):623-34. PubMed ID: 16737935
    [Abstract] [Full Text] [Related]

  • 8. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.
    Murai M, Yoneyama H, Harada A, Yi Z, Vestergaard C, Guo B, Suzuki K, Asakura H, Matsushima K.
    J Clin Invest; 1999 Jul 01; 104(1):49-57. PubMed ID: 10393698
    [Abstract] [Full Text] [Related]

  • 9. CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function.
    Tang B, Ren H, Liu H, Shi Y, Liu W, Dong Y, Yin Y, Miao S.
    Inflamm Res; 2016 Nov 01; 65(11):917-924. PubMed ID: 27423909
    [Abstract] [Full Text] [Related]

  • 10. Role of CXCR3-induced donor T-cell migration in acute GVHD.
    Duffner U, Lu B, Hildebrandt GC, Teshima T, Williams DL, Reddy P, Ordemann R, Clouthier SG, Lowler K, Liu C, Gerard C, Cooke KR, Ferrara JL.
    Exp Hematol; 2003 Oct 01; 31(10):897-902. PubMed ID: 14550805
    [Abstract] [Full Text] [Related]

  • 11. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease.
    Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR.
    J Immunol; 2004 Mar 01; 172(5):3328-36. PubMed ID: 14978141
    [Abstract] [Full Text] [Related]

  • 12. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
    van Den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, Burakoff SJ.
    J Immunol; 2000 Jan 01; 164(1):469-80. PubMed ID: 10605044
    [Abstract] [Full Text] [Related]

  • 13. C-C chemokine receptor 5 and acute graft-versus-host disease.
    Yuan J, Ren HY.
    Immun Inflamm Dis; 2022 Sep 01; 10(9):e687. PubMed ID: 36039647
    [Abstract] [Full Text] [Related]

  • 14. Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody.
    Zhang C, Lou J, Li N, Todorov I, Lin CL, Cao YA, Contag CH, Kandeel F, Forman S, Zeng D.
    J Immunol; 2007 Jan 15; 178(2):838-50. PubMed ID: 17202345
    [Abstract] [Full Text] [Related]

  • 15. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
    Radhakrishnan SV, Palaniyandi S, Mueller G, Miklos S, Hager M, Spacenko E, Karlsson FJ, Huber E, Kittan NA, Hildebrandt GC.
    Biol Blood Marrow Transplant; 2015 Jan 15; 21(1):30-8. PubMed ID: 25445642
    [Abstract] [Full Text] [Related]

  • 16. Mannan-Binding Lectin Promotes Murine Graft-versus-Host Disease by Amplifying Lipopolysaccharide-Initiated Inflammation.
    Heja D, Zhao D, Cody E, Cumpelik A, Lim PC, Prado-Acosta M, Palma L, Dellepiane S, Chun N, Ferrara J, Heeger PS.
    Transplant Cell Ther; 2022 Aug 15; 28(8):472.e1-472.e11. PubMed ID: 35643350
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
    Zhang Y, Shlomchik WD, Joe G, Louboutin JP, Zhu J, Rivera A, Giannola D, Emerson SG.
    J Immunol; 2002 Dec 15; 169(12):7111-8. PubMed ID: 12471148
    [Abstract] [Full Text] [Related]

  • 20. Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation.
    Hildebrandt GC, Olkiewicz KM, Choi S, Corrion LA, Clouthier SG, Liu C, Serody JS, Cooke KR.
    Blood; 2005 Mar 15; 105(6):2249-57. PubMed ID: 15546955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.